Page last updated: 2024-08-23

dianhydrogalactitol and Cancer of Ovary

dianhydrogalactitol has been researched along with Cancer of Ovary in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grönroos, M; Kangas, L; Mäenpää, J; Paul, R; Vanharanta, R	1
Blessing, JA; Blom, J; Ehrlich, CE; Mangan, C; Stehman, FB	1

Other Studies

2 other study(ies) available for dianhydrogalactitol and Cancer of Ovary

Article	Year
Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro. British journal of obstetrics and gynaecology, 1984, Volume: 91, Issue:5 Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Cisplatin; Cystadenocarcinoma; Dianhydrogalactitol; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1984
Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study. Gynecologic oncology, 1983, Volume: 15, Issue:3 Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Prognosis; Sugar Alcohols; Uterine Cervical Neoplasms	1983

Article

Year

Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro.

British journal of obstetrics and gynaecology, 1984, Volume: 91, Issue:5

Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Cisplatin; Cystadenocarcinoma; Dianhydrogalactitol; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen

1984

Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.

Gynecologic oncology, 1983, Volume: 15, Issue:3

Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Prognosis; Sugar Alcohols; Uterine Cervical Neoplasms

1983